Huguenin P N, Zulliger H W, Niederer R
Cilag Ltd., Pharmaceutical Research and Development, Section Biopharmacy/Pharmacokinetics, Schaffhausen, Switzerland.
Arzneimittelforschung. 1988 Feb;38(2):305-8.
To evaluate some prototype oral sustained release formulations of the analgesic drug suprofen (alpha-methyl-4-(2-thienyl-carbonyl)phenylacetic acid, Suprol) in vitro-in vivo correlations were performed. Numerical deconvolution led to hypothetical in vivo absorption curves which were in close agreement with the in vitro dissolution profiles. Furthermore, a linear correlation was obtained between the in vivo and in vitro mean residence times calculated from the blood level data.